TotalMarketCap

Bio-Techne

TECHNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$11.358 B

$72.43 -0.21%

Close of 7 Oct 2026

As of 7 Oct 2026, Bio-Techne (TECH) has a market capitalization of $11.4B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.22B

#1417 by revenue

Earnings

$73.4M

#1421 by earnings

Shares outstanding

156,818,238

Latest filing cover page

P/E ratio

154.7

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →
  1. #9ExelixisEXEL$14.5B
  2. #10Halozyme TherapeuticsHALO$12.5B
  3. #11Bio-TechneTECH$11.4B
  4. #12Twist BioscienceTWST$11.1B
  5. #13ImmunityBioIBRX$10.3B

What if Bio-Techne were worth as much as…

Open the what-if tool →

Gold $28.8T

$183,584.73

Per share 2,535× higher

Bitcoin $1.67T

$10,650.85

Per share 147× higher

Nvidia $5.77T

$36,766.67

Per share 508× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Bio-Techne are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.